Study participants were split into amyloid and tau negative (A-T-, n = 123) vs. positive (A + T+, n = 34) based on Ab42/40 ratio and t-tau levels with the aim to explore the associations in individuals with and without early AD pathology. The gene discussed is MAPT; the disease is Alzheimer disease.